0
Evgen Pharma plc Banner Image

Evgen Pharma plc

  • Ticker EVG
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
Evgen Pharma plc Logo Image
  • 1-10 Employees
  • Based in Nether Alderley, England
Evgen Pharma plc, a clinical stage drug development company, focuses in the development of sulforaphane-based compunds for the treatment of multiple diseases. Its core technology is Sulforadex, a means of synthesizing and stabilizing the naturally occurring compound sulforaphane. The company's lead product is SFX-01, a synthetic and stabilized form of sulforaphane that is in Phase II clinicalMore trials for the treatment of metastatic breast cancer; in preclinical stage for glioma and glioblastoma; and in Phase IIb for treating acute respiratory infections. Evgen Pharma plc was founded in 2007 and is headquartered in Nether Alderley, the United Kingdom.
Evgen Pharma plc

Most Recent Annual Report

Evgen Pharma plc
MOST RECENT 2022 Annual Report

Older/Archived Annual Reports